Skip to content
Lower risk Medical device recall · FDA · Published June 27, 2024

Ventana anti-CD10 antibody recall: False positive results risk

Ventana recalls anti-CD10 (SP67) Rabbit Monoclonal Antibody REF 790-4506 due to potential false positives in lab tests. Affected units have specific UDI codes.

🇺🇸 FDA recall #Z-2644-2024Medical deviceVentana ›
Take action

Contact the company

Recalling firmVentana Medical Systems, Inc.1910 E Innovation Park Dr · Oro Valley, AZ 85755-1962
✎ GovInfoNow plain-language explainer

Ventana is recalling a specific antibody product used in lab testing because it can cause false positive results. This means test results might be inaccurate, which could lead to incorrect diagnoses or treatments. Read more at govinfonow.com/recall/54738-ventana-anti-cd10-antibody-recall-false-positive-results-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/54738-ventana-anti-cd10-antibody-recall-false-positive-results-risk · Updated August 17, 2026 · FDA enforcement record: FDA #Z-2644-2024

Cite this page

“Ventana anti-CD10 antibody recall: False positive results risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/54738-ventana-anti-cd10-antibody-recall-false-positive-results-risk. Based on FDA recall #Z-2644-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2644-2024%22&limit=1).

The FDA announced on June 27, 2024, that Ventana Medical Systems, Inc. is recalling its Ventana anti-CD10 (SP67) Rabbit Monoclonal Primary Antibody due to a potential for false positive results. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Ventana
  • Product: Ventana anti-CD10 (SP67) Rabbit Monoclonic Primary Antibody, REF: 790-4506
  • UDI codes: J04613, J11853, J17541, J25047, J30286, K00982, K06239, K09880, K14266, K19784, K26461, and M00669
  • Quantity: 22,839 kits

The hazard

The antibody may cause high background and off-target staining, which can result in false positive results. The FDA said the recall addresses this potential for inaccurate test outcomes.

Context

GovInfoNow's records show Ventana Medical Systems, Inc. has issued seven other recalls since December 19, 2017. Recent brand recalls include a 2026-04-20 recall for navify Digital Pathology v2.5 Software due to image discrepancies and a 2022-11-18 recall for the PD-L1 (SP142) Assay where light staining may cause false-negative results. Other recent recalls of similar products include the Quidel QuickVue Strep A Test Recall on 2026-04-06, the Immunotech Estrone RIA Kit Recall on 2025-12-15, and the Diagnostica Stago Asserachrom HPIA Kit Recall on 2025-12-15.

How to tell if you have this one

Check for the product code REF: 790-4506 on the label. The unique device identifier (UDI) codes include 04015630972579, J04613, J11853, and other listed codes.

  • Brand
    Ventana
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the product code REF: 790-4506 and the unique device identifier (UDI) codes listed in the recall notice.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 48 states.

Alaska: named in the noticeAKMaine: nationwideMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Jun 27, 202412. FDA classified it Class II: Aug 16, 202423. Published in FDA’s Enforcement Report: Aug 28, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product dangerous for regular use?

No, this is a laboratory product used by professionals. The recall is for potential false positives in lab tests, not a safety hazard for end users.

Do I need to stop using this product?

The recall does not require stopping use; it's for lab testing accuracy. Affected users should check the UDI codes and contact Ventana if needed.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2644-2024 (June 27, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2644-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA